Candriam SCA’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-500,033
| Closed | -$4.7M | – | 689 |
|
|
2024
Q3 | $4.7M | Hold |
500,033
| – | – | 0.03% | 369 |
|
|
2024
Q2 | $4.01M | Sell |
500,033
-559,109
| -53% | -$4.48M | 0.02% | 371 |
|
|
2024
Q1 | $15.7M | Sell |
1,059,142
-668,680
| -39% | -$9.91M | 0.1% | 198 |
|
|
2023
Q4 | $14M | Sell |
1,727,822
-1,020,031
| -37% | -$8.29M | 0.1% | 215 |
|
|
2023
Q3 | $12.5M | Buy |
2,747,853
+1,020,037
| +59% | +$4.64M | 0.09% | 203 |
|
|
2023
Q2 | $12.2M | Buy |
1,727,816
+33,896
| +2% | +$239K | 0.09% | 221 |
|
|
2023
Q1 | $9.53M | Buy |
1,693,920
+140,000
| +9% | +$787K | 0.07% | 266 |
|
|
2022
Q4 | $9.93M | Sell |
1,553,920
-115,000
| -7% | -$735K | 0.07% | 280 |
|
|
2022
Q3 | $16M | Buy |
1,668,920
+40,000
| +2% | +$383K | 0.11% | 195 |
|
|
2022
Q2 | $18M | Buy |
1,628,920
+476,335
| +41% | +$5.26M | 0.15% | 151 |
|
|
2022
Q1 | $19.2M | Buy |
1,152,585
+256,221
| +29% | +$4.27M | 0.13% | 170 |
|
|
2021
Q4 | $17.1M | Buy |
896,364
+47,712
| +6% | +$911K | 0.11% | 194 |
|
|
2021
Q3 | $20.9M | Sell |
848,652
-171,774
| -17% | -$4.24M | 0.14% | 169 |
|
|
2021
Q2 | $26.6M | Buy |
1,020,426
+428,376
| +72% | +$11.1M | 0.18% | 134 |
|
|
2021
Q1 | $26.4M | Sell |
592,050
-12
| -0% | -$535 | 0.22% | 121 |
|
|
2020
Q4 | $27.5M | Sell |
592,062
-93,019
| -14% | -$4.32M | 0.22% | 122 |
|
|
2020
Q3 | $22.6M | Sell |
685,081
-72,575
| -10% | -$2.39M | 0.21% | 121 |
|
|
2020
Q2 | $20.8M | Buy |
757,656
+584,152
| +337% | +$16M | 0.22% | 115 |
|
|
2020
Q1 | $4.7M | Buy |
173,504
+26
| +0% | +$704 | 0.05% | 360 |
|
|
2019
Q4 | $4.8M | Buy |
173,478
+103,978
| +150% | +$2.88M | 0.05% | 367 |
|
|
2019
Q3 | $1.27M | Buy |
69,500
+21,500
| +45% | +$391K | 0.02% | 563 |
|
|
2019
Q2 | $1.17M | Buy |
+48,000
| New | +$1.17M | 0.01% | 619 |
|
|
2018
Q3 | – | Sell |
-112,000
| Closed | -$1.43M | – | 826 |
|
|
2018
Q2 | $1.43M | Buy |
112,000
+15,000
| +15% | +$192K | 0.02% | 545 |
|
|
2018
Q1 | $1.64M | Buy |
+97,000
| New | +$1.64M | 0.03% | 515 |
|